Immix Biopharma Inc.
IMMX | NASDAQ
$7.20
-$0.77 (-9.66%)
At close: Nov 4, 2026, 4:00 PM ET
$7.27
+$0.07 (+0.97%)
After-hours:
Nov 5, 2026, 4:27 PM ET
Market Data
Market Cap $596.9M
Enterprise Value $429.63M
Beta 0.11
Average Volume 1.68M
Shares Outstanding (Diluted) 63.77M
Shares Change YoY 112.69%
Institutional Ownership 88.36%
Exchange NASDAQ
ISIN US45258H1068
Price Performance
Price Change 1M -25.3%
Price Change 3M -28.4%
Price Change 6M -24.5%
Price Change YTD 37.7%
Price Change 1Y 137.6%
Price Change 3Y 67.0%
Price Change 5Y N/A
1M CAGR (ann.) -41.8%
1Y CAGR (ann.) 97.8%
5Y CAGR (ann.) N/A
All-Time CAGR 15.0%
Valuation
PE Ratio -9.06
Forward PE 7.73
PEG Ratio 0.65
Forward PEG -1.01
PS Ratio N/A
Forward PS 25.00
PB Ratio 2.89
P/FCF Ratio -16.90
P/Adj. FCF Ratio -16.03
P/OCF Ratio -13.28
EV/Sales N/A
EV/EBIT -10.58
EV/EBITDA -10.67
EV/FCF -10.99
Earnings Yield -11.0%
FCF Yield -5.9%
Adj. FCF Yield -6.2%
Financial Health
Net Cash $232.11M
Total Debt $1M
Cash & Short-Term Investments $232.11M
Total Assets $239.11M
Current Ratio 25.13
Quick Ratio 25.13
Debt / Equity Ratio 0.00
Debt / EBITDA -0.02
Debt / FCF -0.03
OCF / Debt -38.43
Interest Coverage 0.00
Altman Z-Score 38.72
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -5.4%
Returns
Return on Assets -16.7%
Return on Equity -38.4%
Return on Invested Capital -18.2%
Return on Capital Employed -18.2%
Return on Tangible Assets -16.7%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -1.2%
EPS CAGR 5Y 36.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y -52.6%
FCF CAGR 5Y -45.3%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y 9.8%
Revenue Growth Next 3Y N/A
Earnings Date Nov 6, 2026
EPS Estimate (next Q) -$0.18
EPS Growth Est (next Q) -25.0%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $22.67
Price Target Upside 184.4%
Cash Flow
Operating Cash Flow $-38.5M
Free Cash Flow $-39.09M
Adj. Free Cash Flow $-41.21M
FCF Per Share -$0.61
OCF Per Share -$0.60
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-41.82M
EBITDA $-40.28M
Net Income $-39.92M
EPS (Diluted) -$0.88
Revenue / Employee N/A
Profit / Employee $-1.9M
Employees 21
Add to Watchlist
Select watchlists to add or remove IMMX